Abstract
Background. This study was conducted to evaluate the significance of postoperative adjuvant chemotherapy using mitomycin C (MMC) and UFT (tegafur; uracil at 1:4 molar ratio) in combination for rectal cancer.
Methods. The Japanese Foundation for Multidisciplinary Treatment of Cancer conducted a prospective randomized controlled trial in 834 patients who had undergone curative resection for rectal cancer (T3 or T4 and/or Nl, N2, or N3 according to TNM classification) from February 1986 to December 1988. The patients were randomly allocated to a treatment group (MMC/UFT, 416 patients) and a control group (surgery alone, 418 patients). For the patients in the treatment group, 20 mg of MMC was sprinkled on the operating field upon completion of surgery. MMC was injected intravenously (6 mg/m2) on day 7, and then once a month for months 1–6 after surgery. UFT was administered at 400mg/day, orally, for 1 year, beginning 3 weeks after surgery.
Results. There was no difference, in the 5-year survival rate between the two groups, but the 5-year disease-free survival rate in the MMC/UFT group (68.9%) was significantly higher than that (59.3%) in the control group (P = 0.006). The 5-year cumulative local recurrence rate was significantly lower in the MMC/UFT group (11.6%) than in the control group (19.0%) (P = 0.007).
Conclusion. We conclude that the adjuvant use of longterm oral UFT and intermittent MMC (i.v.) improves the disease-free survival rate of patients with curatively resected rectal cancer (T3 or T4 and/or N1, N2, or N3).
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Japanese Research Society for Cancer of the Colon and Rectum (1995) Multi-institutinal registry of large bowel cancer in Japan. Vol 11 (cases treated in 1986)
Hojo K, Kajitani T (1986) Adjuvant chemotherapy of colorectal cancer: Results of prospectively randomized trials (in Japanese). Jpn J Cancer Chemother 13:3063–3073
Nishida O, Uchino J, Kikuchi K, et al. (1993) Cooperative study of surgical adjuvant chemotherapy for colorectal cancer: Five-year results after surgery (in Japanses). Jpn J Cancer Chemother 20:101–108
The Colorectal Cancer Chemotherapy Study Group of Japan (1995) Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 25:91–103
Ota K, Taguchi T, Kimura K (1988) Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22:333–338
Takahashi Y, Kikuchi R, Ueno M, Mai M (1987) Effect of combination of UFT and MMC(UFT-M Therapy) on human colonic cancer xenotransplanted in nude mice (in Japanese). Jpn J Cancer Chemother 14:1345–1347
Japanese Research Society for Cancer of Colon and Rectum (1983) General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jpn J Surg 13:557–573
Japan Society for Cancer Therapy (1993) Criteria for the evaluation of the clinical effects of solid cancer chemotherapy. J Jpn Soc Cancer Ther 28:101–130
Wolmark N, Fisher B, Rockette H, et al. (1988) and other NSABP Investigators. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01. J Nall Cancer Inst 80:30–36
Fisher B, Wolmark N, Rockette H, et al. (1988) and other NSABP Investigators. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 80:21–29
Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472
Kato T, Hirai T, Arai Y (1994) Treatment of locally recurrent rectal cancer (in Japanese). Gastroenterol Surg 17:317–324
Sugihara K, Hojo K, Moriya Y, et al. (1991) Hepatic resection of metastases from colorectal cancers (in Japanese). Jpn J Gastroenterol Surg 24:1147–1151
Yasui K, Kato T (1993) Significance and indication of anatomical major hepatic resection of the liver metastases from colorectal cancer (in Japanese). Gastroenterol Surg 16:1693–1699
Goya T (1991) Pulmonary resection of metastases from colorectal cancer (in Japanese). Shujutsu (Operation) 45:1505–1511
Ikeda E, Kodaira S, Teramoto T, et al. (1996) Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer (in Japanese). Jpn J Cancer Chemother 23:1291–1298
Author information
Authors and Affiliations
About this article
Cite this article
Kodaira, S., Kikuchi, K., Kunii, Y. et al. Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the Cooperative Project No.7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer. Int J Clin Oncol 3, 357–364 (1998). https://doi.org/10.1007/BF00539213
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00539213